upadacitinib
abbvie
[' upa ', 'upadacitinib']
d haens #ecco2023 post-hoc analysis of #upa licensing studies focussing on fatigue to see symptoms which matter to patients being looked at even with the caveats of post-hoc &amp; merger of symptoms even now the improvement of fatigue is dismally low 
IBD clinician& researcher @IBDHull.Chair:Research Committee of @BritSocGastro . Chair of ECCO CLiNCOM. @NIHR (Y&H ) lead. own views ,RT🚫endorse.⚽️ @LFC fan.